Valuation : Olympus Corporation

Market Cap 2,088B 13.54B 11.64B 10.96B 10B 18.66B 1,284B 18.75B 130B 50.22B 656B 50.86B 49.75B P/E 2027 *
20x
P/E 2028 * 17.3x
Enterprise Value 2,170B 14.07B 12.1B 11.38B 10.39B 19.39B 1,334B 19.49B 135B 52.19B 682B 52.85B 51.69B EV / Sales 2027 *
2.01x
EV / Sales 2028 * 1.93x
Free-Float
94.58%
Yield 2027 *
1.56%
Yield 2028 * 1.64%
1 day-0.18%
1 week-3.32%
Current month-5.24%
1 month-4.74%
3 months+13.10%
6 months+40.40%
Current year+0.19%
1 week 10.76
Extreme 10.76
11.22
1 month 10.76
Extreme 10.76
11.64
Current year 7.01
Extreme 7.014
11.64
1 year 7.01
Extreme 7.014
11.74
3 years 7.01
Extreme 7.014
17.5
5 years 7.01
Extreme 7.014
23.3
10 years 5.94
Extreme 5.94
23.3
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-3.32% - - 13.54B
-1.75%+0.42%+23.66%+16.35% 223B
-1.17%-0.82%+3.32%-17.37% 144B
-4.51%-5.17%-25.50%+17.42% 124B
-5.90%-6.45%-58.41%-16.50% 65.19B
-3.54%-4.43%+8.12%+17.08% 49.99B
-0.88%-2.13%-18.25%-14.67% 50.49B
-2.66%-2.05%+14.61%+28.83% 41.4B
-1.58%-0.72%+30.24%+52.87% 39.59B
-3.28%+1.90%+114.97%+33.28% 31.87B
Average -1.82%-1.93%+10.31%+13.03% 85.5B
Weighted average by Cap. -1.42%-1.80%+4.86%+8.68%

Financials

2027 *2028 *
Net sales 1,080B 7.01B 6.02B 5.67B 5.17B 9.65B 664B 9.7B 67.15B 25.98B 340B 26.31B 25.73B 1,118B 7.25B 6.23B 5.86B 5.35B 9.99B 687B 10.04B 69.48B 26.88B 351B 27.22B 26.63B
Net income 105B 681M 585M 551M 502M 938M 64.53B 943M 6.52B 2.52B 32.98B 2.56B 2.5B 122B 789M 679M 638M 583M 1.09B 74.81B 1.09B 7.56B 2.93B 38.24B 2.96B 2.9B
Net Debt 81.71B 530M 456M 429M 391M 730M 50.24B 734M 5.08B 1.96B 25.68B 1.99B 1.95B 64.09B 416M 357M 336M 307M 573M 39.4B 575M 3.98B 1.54B 20.14B 1.56B 1.53B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-09-09 10.76 -1.19% 0
26-09-08 €10.89 -0.95% 0
26-09-07 €11.00 -1.65% 0
26-09-04 €11.18 -0.31% 0
26-09-03 €11.22 +0.76% 0
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,965.00JPY
Average target price
2,161.54JPY
Spread / Average Target
+10.00%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!